Form 4: Exagen Inc. CFO, Jeffrey G. Black, Reports Stock Transactions

Exagen Inc.'s Chief Financial Officer, Jeffrey G. Black, acquired 22,298 shares of common stock at an average price of $2.98 on November 15, 2024.

Summary

• Jeffrey G. Black, the Chief Financial Officer of Exagen Inc., reported a transaction involving the company's common stock.
• On November 15, 2024, Mr. Black acquired 22,298 shares of common stock.
• The shares were purchased at a weighted average price of $2.98 per share.
• The price range for the transactions was between $2.84 and $3.25 per share.
• Following this transaction, Mr. Black directly owns 274,492 shares of Exagen Inc. common stock.

Sentiment

Score: 6

Explanation: The document is neutral in sentiment, as it simply reports a stock transaction by a company executive. It is neither positive nor negative for the company's performance.

Positives

• The CFO's purchase of shares could be seen as a positive signal of confidence in the company's future.

Industry Context

This is a routine filing related to insider trading activity and is common for publicly traded companies. It provides transparency into the transactions of company executives.

Comparison to Industry Standards

• SEC Form 4 filings are a standard practice for publicly traded companies in the United States.
• The reporting requirements are consistent across all companies and are designed to ensure transparency in insider trading.
• The transaction details are typical of what is seen in similar filings from other companies.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider trading activity.
• The purchase of shares by the CFO could be interpreted as a positive signal by investors.

Key Dates

Keywords

Exagen Inc., Jeffrey G. Black, stock transaction, common stock, insider trading, SEC Form 4, CFO